Adipose tissue (AT), which was poorly studied until the middle of the last century, has experienced a boom with the increase in obesity in the western world and in some emerging countries. It is mainly composed with mature adipocytes which do not divide in vivo. Their numbers increase especially during early childhood and adolescence and remain stable in adulthood. The rate of adipocyte turnover in subcutaneous AT is about 10% per year. The adipocytes of an obese man are 730 times bigger in volume and 35% more numerous than the adipocytes of a thin man. The fight against obesity is essentially at the
level of preventing the onset of obesity in young people.
THE NUMBER OF ADIPOCYTES INCREASES DURING CHILDHOOD AND ADOLESCENCE AND REMAINS STABLE IN ADULTHOOD.
■ Storage via the synthesis of triglycerides or lipogenesis: results from the combination of glucose on
the one hand, and lipids on the other hand, both penetrating through the membrane of the adipocyte with the help of transporters.
■ Fat release via the degradation of triglycerides or lipolysis: triglycerides are hydrolysed into glycerol
and three free fatty acids. This process is conditioned by two receptors: The Alpha receptors which inhibit
lipolysis and the Beta receptors which stimulate it. The released fatty acids join the bloodstream and are
transported to the muscles to provide energy.
THE NUMBER OF ALPHA AND BETA RECEPTORS IS DISTRIBUTED DIFFERENTLY
DEPENDING ON THE LOCATION OF THE FAT:
■ In intra-abdominal AT, there are as many Alpha receptors as Beta receptors.
■ In subcutaneous femoral AT: the number of Beta receptors is much lower than the number of Alpha
receptors. In addition, this tissue is lazy and responds very poorly to lipolysis signals. Therefore, it is
very difficult to remove fat in this area, even with diet or physical activity.
AT is a complex tissue that is not limited to adipocytes alone. It also includes immune cells such as
macrophages and T-lymphocytes, as well as stem cells involved in the renewal of fat cells and the
expansion of the vascular network. Thereby the AT is a reservoir of stem cells. Although this type of cell
exists in other tissues, AT cells are readily available and are of interest to practitioners of plastic and
reconstructive surgery.
In recent years, the adipocyte has emerged as an "intelligent" cell, capable of "talking" to other organs via different hormones and in particular:
■ LEPTIN OR SATIETY HORMONE: Its role is to inform the brain about the state of energy reserves. People with a leptin mutation are massively obese. During fasting or starvation, the leptin level decreases which sends a signal to the brain to increase food intake and decrease energy expenditure.
■ ADIPONECTIN: Its action improves insulin sensitivity. In addition, adiponectin can act in the central nervous system to stimulate appetite, reduce energy expenditure, and affect vessel formation.
■ ASPROSINE: This is a recently discovered hormone that acts on the liver to release glucose into the blood.
■ ANGIOTENSINOGEN & ANGIOTENSIN II: Angiotensinogen is the precursor to angiotensin.
These peptides have a role in the development of AT and the regulation of blood pressure. AT is the main
source of angiotensinogen after the liver.
SOURCES:
- Le tissu adipeux : un organe aux ressources insoupçonnées. Lafontan M. Cahiers de nutrition et de diététique (2015) 50, 5S1-5S7.
- Physiologie de l’adipocyte. Information Vichy. Janvier 2006 – Les nouvelles esthétiques p.91.
- Le tissu adipeux : un véritable organe endocrine. Gaillard R. C. Rev Med Suisse 2003; volume -1.22822.
- Altered adipose tissue and adipocyte function in the pathogenesis of metabolic syndrome. Kahn CR, Wang G, Lee KY. J Clin Invest. 2019; 129(10):3990-4000. DOI:10.1172/JCI129187